Skip to main content
. 2021 Jul 22;11:15042. doi: 10.1038/s41598-021-94468-y

Table 2.

Demographic and clinical data of the comorbidity-controlled dataset.

Variables LC*
(N = 8)
COPD
(N = 7)
ILD
(N = 10)
P value*
Age (yrs.±SD) 58.5 ± 14.1 56.7 ± 13.9 62.9 ± 12.3 NS
Sex, men N (%) 5 (62.5) 6 (85.7) 8 (80.0) NS
Smoking status N (%)
Smoker 3 (37.5) 2 (28.6) 2 (20.0) NS
Former smoker 2 (25.0) 3 (42.6) 6 (60.0)
Non-smoker 3 (37.5) 2 (28.6) 2 (20.0)
Pack Per Year 37.6 ± 18.2 64.5 ± 37.4 35.7 ± 17.7 NSa
LC Diagnosis N (%)
NSCLC 7 (87.5) NA
ADC 5 (62.5)
Unknown 2 (25.0)
SCLC 1 (12.5)
COPD Diagnosis N (%)
GOLD 2 5 (71.4) NA
Unknown 2 (28.6)
ILD Diagnosis N (%)
HP 3 (30.0) NA
Sarcoidosis 2 (20.0)
IPF 1 (10.0)
Other 4 (40.0)

*P values based on Kruskal–Wallis test or chi-square (normal distributed or categorical variables, respectively) for the comparison of the three groups, lung cancer (LC), chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). HP- Hypersensitivity pneumonitis; NS—Non-significant (p value > 0.05); NA—Not applicable. a—results based in pairwise Welch's t-tests.